Trial intelligence / Profile preview

Cohort of antithrombotic use and optimal INR level in patients with non-valvular atrial fibrillation in Thailand

TCTR20160113002Phase 4Recruiting

Sponsor
Health Systems Research Institute
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of warfarin in Atrial fibrillation (AFib), sponsored by Health Systems Research Institute. Started Nov 2015; status: recruiting.

02

Drugs

warfarin
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on TCTR20160113002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160113002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call